CMS Tracheostomy Speaking Valve Coverage Policy Update (NCD 247) — What Billing Teams Need to Know
The Centers for Medicare & Medicaid Services (CMS) has modified National Coverage Determination 247, which governs Medicare coverage of tracheostomy speaking valves. This update reinforces and clarifies the classification of the speaking valve as a medically necessary accessory to the trachea tube—a distinction that has direct implications for how your team documents and bills these devices. If you manage billing for pulmonology, otolaryngology, or long-term acute care patients on tracheostomy tubes, this policy deserves your attention.
| Field | Detail |
|---|---|
| Payer | CMS (Medicare) |
| Policy | Tracheostomy Speaking Valve |
| Policy Code | NCD 247 |
| Change Type | Modified |
| Effective Date | 2026-03-12 |
| Impact Level | Medium |
| Specialties Affected | Pulmonology, Otolaryngology (ENT), Speech-Language Pathology, Long-Term Acute Care, Skilled Nursing Facilities |
| Key Action | Confirm documentation frames the speaking valve as a medically necessary accessory that enhances trachea tube function—not as a standalone device. |
What NCD 247 Actually Says About CMS Tracheostomy Speaking Valve Coverage
The Centers for Medicare & Medicaid Services covers the tracheostomy speaking valve under the Prosthetic Devices benefit category. The policy's logic is worth understanding at a structural level, because it directly shapes how medical necessity documentation should be written.
CMS has determined that the trachea tube itself meets the definition of a prosthetic device. The tracheostomy speaking valve is classified as an add-on accessory to that tube—not a separate, independent device. The policy states that the valve "enhances the function of the tube," effectively making the trachea tube system a more effective prosthesis.
Because of this classification, the speaking valve is covered as an element of the trachea tube—the framing is that it makes the underlying prosthetic device work better, not that it is a distinct item with its own standalone justification. This matters enormously for how your clinical and billing teams construct the medical record.
Medicare Benefit Category: Why Prosthetic Devices Classification Matters
When a device falls under the Prosthetic Devices benefit category, the coverage framework is different from durable medical equipment (DME) or supplies. Prosthetic devices replace the function of a permanently absent or nonfunctional body part. CMS has extended this framework to the trachea tube—and by extension, to the speaking valve as an accessory that improves the prosthetic function.
This classification has practical consequences for your billing team:
- Supplier type may affect which billing pathway applies depending on the care setting
- Medical necessity documentation should reference the functional enhancement to the trachea tube, not simply the patient's communication needs in isolation
- Coverage decisions tie back to the prosthetic device framework, which means phrasing your documentation around "prosthetic function" and "functional enhancement" is more defensible than generic language
If your documentation currently frames the speaking valve purely as a communication aid or speech therapy tool without connecting it back to the trachea tube's prosthetic function, that documentation may not align with the policy's stated rationale.
Medical Necessity Criteria Under CMS NCD 247
The modified NCD 247 does not enumerate an exhaustive list of specific clinical criteria, diagnosis codes, or CPT requirements. However, the policy's language implies the following coverage framework:
For coverage to apply:
| # | Covered Indication |
|---|---|
| 1 | The patient must have a trachea tube in place that qualifies as a prosthetic device |
| 2 | The speaking valve must be positioned as an add-on accessory to that trachea tube |
| 3 | The valve must be documented as enhancing the function of the tube—making the prosthetic system more effective |
Documentation should clearly establish:
| # | Covered Indication |
|---|---|
| 1 | The presence and medical necessity of the underlying tracheostomy |
| 2 | Why the speaking valve improves the functional outcome of the trachea tube |
| 3 | The treating clinician's clinical rationale connecting the valve to the prosthetic device framework |
CMS notes explicitly that this may not be an exhaustive list of all applicable Medicare benefit categories—meaning in some clinical scenarios, additional benefit category arguments may be available. Your team should evaluate individual cases accordingly.
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
Affected Codes
The current version of NCD 247 as modified does not list specific CPT or HCPCS codes within the policy document. CMS has not enumerated covered codes, non-covered codes, or associated ICD-10-CM diagnosis codes in this policy record.
What this means for your billing team: You cannot rely on this NCD alone to confirm a specific HCPCS code is covered. You will need to cross-reference your DME or prosthetics fee schedule and any applicable Local Coverage Determinations (LCDs) from your Medicare Administrative Contractor (MAC) to identify the correct billing codes for tracheostomy speaking valves in your region.
Reach out to your MAC directly or consult their published LCDs to confirm which HCPCS codes align with this NCD's coverage framework in your jurisdiction.
What Your Billing Team Should Do
| # | Action Item |
|---|---|
| 1 | By March 12, 2026, audit your tracheostomy speaking valve documentation templates. Confirm that physician and clinical notes frame the speaking valve as an accessory that enhances trachea tube function—not as a standalone communication device. Update any templates that don't reflect NCD 247's prosthetic device rationale. |
| 2 | Contact your MAC to identify applicable HCPCS codes. Because NCD 247 does not list specific billing codes, your Medicare Administrative Contractor's LCD and coverage article for prosthetic devices and tracheostomy accessories is the authoritative source for the correct codes to submit. Document which HCPCS codes your MAC recognizes under this NCD. |
| 3 | Review claims submitted in the past 12 months for tracheostomy speaking valves. Identify any denials or pending claims that may have been framed incorrectly—particularly those that treated the speaking valve as an independent item rather than a trachea tube accessory—and assess whether corrected documentation and a reopening request is warranted. |
| 4 | Brief your speech-language pathologists and pulmonologists on the coverage rationale. Clinical staff often document from a communication and therapy perspective. They need to understand that CMS's coverage basis is prosthetic device enhancement—so their notes should include language that connects the valve to improved trachea tube function. |
| 5 | Flag this policy in your denials management workflow. If a claim for a tracheostomy speaking valve is denied, NCD 247's prosthetic device classification is your primary appeal argument. Make sure your appeals team has the policy language readily available. |
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.